Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Stem Cell Usage

The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients

Abstract

We retrospectively reviewed the engraftment kinetics following unrelated cord blood transplantation (CBT) in association with the post-thaw colony-forming units-granulocyte/macrophage (CFU-GM) number along with the numbers of total nucleated cells (TNC), CD34+ cells and CD3+ cells. A total of 71 cord blood units prepared for 53 patients (double-unit CBT in 18 patients) were evaluated. Either the number of infused CFU-GM or CD34+ cells was significantly lower in patients who failed to achieve engraftment (P=0.028 and 0.005, respectively). Post-thaw CFU-GM, TNC and CD34+ cells correlated with the speed of neutrophil engraftment (P=0.004, 0.037 and 0.004, respectively), whereas only CFU-GM showed a significant correlation with platelet engraftment (r=−0.385, P=0.024). In double-unit transplants, the number of CFU-GM was the only significant factor predicting engraftment of the predominating unit (P=0.006). We conclude that the post-thaw CFU-GM number is a reliable predictor of rapid engraftment after CBT as well as of the predominating unit in double-unit transplants. Thus, it would be important to perform post-thaw CFU-GM assay on cryopreserved aliquots from several candidate cord blood units in advance before CBT to avoid selecting the unit that might possess a low clonogenic potential.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Gluckman E . Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000; 28: 1197–1205.

    Article  CAS  Google Scholar 

  2. Wagner JE, Barker JN, DeFor TE, Barker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.

    CAS  PubMed  Google Scholar 

  3. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collection in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961–3969.

    CAS  PubMed  Google Scholar 

  4. Diaz MA, Alegre A, Villa M, Granda A, de la Vega A, Ramirez M et al. Pediatric experience with autologous peripheral blood progenitor cell transplantation: influence of CD34+ cell dose in engraftment kinetics. Bone Marrow Transplant 1996; 18: 699–703.

    CAS  PubMed  Google Scholar 

  5. Miflin G, Russell NH, Hutchinson RM, Morgan G, Potter M, Pagliuca A et al. Allogeneic peripheral blood stem cell transplantation for haematological malignancies – an analysis of kinetics of engraftment and GVHD risk. Bone Marrow Transplant 1997; 19: 9–13.

    Article  CAS  Google Scholar 

  6. Lee SH, Lee MH, Lee JH, Min YH, Lee KH, Cheong JW et al. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission. Biol Blood Marrow Transplant 2005; 11: 122–128.

    Article  Google Scholar 

  7. Schuurhuis GJ, Muijen MM, Oberink JW, de Boer F, Ossenkoppele GJ, Broxterman HJ et al. Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen–thawed peripheral blood stem cell transplants. Bone Marrow Transplant 2001; 27: 487–498.

    Article  CAS  Google Scholar 

  8. de Boer F, Drager AM, Pinedo HM, Kessler FL, Monnee-van Muijen M, Weijers G et al. Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts. J Hematother Stem Cell Res 2002; 11: 951–963.

    Article  Google Scholar 

  9. Greco NJ, Seetharaman S, Kurtz J, Lee WR, Moroff G . Evaluation of the reactivity of apoptosis markers before and after cryopreservation in cord blood CD34(+) cells. Stem Cells Dev 2006; 15: 124–135.

    Article  CAS  Google Scholar 

  10. Hamza NS, Lisgaris M, Yadavalli G, Nadeau L, Fox R, Fu P et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 2004; 124: 488–498.

    Article  Google Scholar 

  11. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997; 337: 373–381.

    Article  CAS  Google Scholar 

  12. Douay L, Gorin NC, Mary JY, Lemarie E, Lopez M, Najman A et al. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol 1986; 14: 358–365.

    CAS  PubMed  Google Scholar 

  13. Emminger W, Emminger-Schmidmeier W, Hocker P, Hinterberger W, Gadner H . Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children. Bone Marrow Transplant 1989; 4: 415–420.

    CAS  PubMed  Google Scholar 

  14. Rowley SD, Piantadosi S, Santos GW . Correlation of hematologic recovery with CFU-GM content of autologous bone marrow grafts treated with 4-hydroperoxycyclophosphamide. Culture after cryopreservation. Bone Marrow Transplant 1989; 4: 553–558.

    CAS  PubMed  Google Scholar 

  15. al-Fiar F, Prince HM, Imrie K, Stewart AK, Crump M, Keating A . Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: value of the colony-forming unit granulocyte-macrophage (CFU-GM) assay. Cell Transplant 1997; 6: 491–495.

    Article  CAS  Google Scholar 

  16. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P . Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717–2722.

    CAS  PubMed  Google Scholar 

  17. Iori AP, Cerretti R, De Felice L, Screnci M, Mengarelli A, Romano A et al. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation. Bone Marrow Transplant 2004; 33: 1097–1105.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank resident physicians and nurses for their hard work, compassion and diligence in caring for the patients.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H H Koo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoo, K., Lee, S., Kim, HJ. et al. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant 39, 515–521 (2007). https://doi.org/10.1038/sj.bmt.1705629

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705629

Keywords

This article is cited by

Search

Quick links